A registry-based observational study assessing clinical outcomes in familial adenomatous polyposis in patients receiving celecoxib (Celebrex, Onsenal) compared with control patients.

Trial Profile

A registry-based observational study assessing clinical outcomes in familial adenomatous polyposis in patients receiving celecoxib (Celebrex, Onsenal) compared with control patients.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2010

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Mar 2010 Actual Patient numbers amended from 72 to 68 as reported by ClinicalTrials.gov.
    • 15 Sep 2008 Actual patient number (72) added as reported by ClinicalTrials.gov.
    • 15 Sep 2008 Planned end date added (1 May 2008) as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top